Diabetes Management Diabetes Management Medications

This category covers oral medicines that lower blood sugar in type 2 diabetes. They work in different ways and are often combined, alongside diet, activity and regular monitoring.

Medicines in the Diabetes Management category

Rybelsus

Semaglutide

3 · 7 · 14mg

Indicated to manage type 2 diabetes and developed to support blood sugar control and alleviate weight-related health risks in patients.

From $15.72 / tablet View

Glucophage

Metformin

500 · 850 · 1000mg

Formulated to target type 2 diabetes mellitus to alleviate hyperglycemia through improved insulin sensitivity.

From $0.25 / tablet View

Farxiga

Dapagliflozin

5 · 10mg

Developed to target type 2 diabetes mellitus to support healthy blood glucose levels.

From $0.27 / tablet View

Januvia

Sitagliptin

50 · 100mg

Indicated to manage blood glucose levels in adults and formulated to support glycaemic control in type 2 diabetes.

From $3.04 / tablet View

Invokana

Canagliflozin

100mg

Indicated to manage type 2 diabetes mellitus to support improved glycaemic control.

From $3.90 / tablet View

Actos

Pioglitazone

15 · 30mg

Designed to target elevated blood sugar, indicated to alleviate insulin resistance and support better glucose control in type 2 diabetes.

From $0.49 / tablet View

Micronase

Glibenclamide

2.5 · 5mg

Designed to target blood glucose levels utilized to support type 2 diabetes management.

From $0.36 / tablet View

Amaryl

Glimepiride

1 · 2 · 4mg

Formulated to support blood glucose control, intended to help manage type 2 diabetes by stimulating natural insulin production from the pancreas.

From $0.69 / tablet View

Glucovance

Metformin, Glibenclamide

400/2.50 · 500/5mg

Designed to manage type 2 diabetes mellitus to support insulin sensitivity and blood glucose regulation.

From $0.44 / tablet View

Glucophage Sr

Metformin

500mg

Indicated to manage blood glucose levels and formulated to support type 2 diabetes treatment.

From $0.74 / tablet View

Glycomet

Metformin

500mg

Intended to target high blood sugar levels and to support metabolic control in diabetes.

From $0.31 / tablet View

Glucophage Xr

Metformin

1000mg

Utilized to manage type 2 diabetes mellitus and indicated to support glucose control effectively for improved endocrine function.

From $1.36 / tablet View

Tradjenta

Linagliptin

5mg

Utilized to manage type 2 diabetes mellitus to support glycaemic control.

From $2.34 / tablet View

Vsmall

Vildagliptin

50mg

Indicated for type 2 diabetes, utilized to target glycaemic levels and alleviate blood sugar imbalances to support long-term metabolic health.

From $1.62 / tablet View

Glucotrol

Glipizide

5 · 10mg

Indicated to address type 2 diabetes mellitus to mitigate high blood sugar levels.

From $0.27 / tablet View

Prandin

Repaglinide

0.5 · 1 · 2mg

This product is formulated for type 2 diabetes mellitus intended to mitigate glucose swings and support long-term metabolic control.

From $0.64 / tablet View

Precose

Acarbose

25 · 50mg

This medication is indicated to support blood sugar control and formulated to target post-prandial hyperglycaemia in type 2 diabetes mellitus.

From $0.71 / tablet View

Glucotrol Xl

Glipizide

5 · 10mg

Indicated to manage blood sugar levels in type 2 diabetes mellitus and intended to support patients in maintaining glycaemic control.

From $0.40 / tablet View

Jentadueto

Linagliptin, Metformin

2.5/500mg

Indicated to manage glycemic control in adults and developed to support blood glucose reduction in type 2 diabetes.

From $1.53 / tablet View

Metaglip

Glipizide, Metformin

2.5/500 · 5/500mg

Formulated to manage type 2 diabetes mellitus, this combined therapy is utilized to support blood glucose control and to mitigate glycemic fluctuations.

From $0.34 / tablet View

What’s in this category

Conditions it covers

These medicines are used for type 2 diabetes mellitus and related metabolic problems.

Diabetes Management in Asia

Type 2 diabetes is rising faster in Asia than almost anywhere, with some of the world’s highest rates in Singapore, Malaysia and India. Asian populations can develop diabetes at a lower body weight than Western averages, so early screening and treatment matter across the region even without obvious risk factors.

Related articles